HST Global, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
July 26, 2022 at 08:32 pm
Share
HST Global, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 0.035513 million compared to USD 0.038879 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
For the six months, net loss was USD 0.073727 million compared to USD 0.077618 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
HST Global, Inc. is an integrated health and wellness biotechnology company. The Company is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The Company intends to acquire innovative products for the treatment of life-threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The Company has not generated any revenue.
HST GLOBAL, INC. 
